It has been demonstrated that NPAS2 inhibits mitochondrial biogenesis and OXPHOS by downregulating peroxisome proliferator-activated receptor gamma coactivator-1 α (PGC-1α) by transcriptionally upregulating HIF-1α in HCC cells. This evidence concerns the gene NPAS2 and hepatocellular carcinoma.